Theresa Boyle, MD, PhD, discusses the current approach to biomarker testing in lung cancer.
Theresa Boyle, MD, PhD
Advertisement
Articles by Theresa Boyle, MD, PhD
Theresa Boyle, MD, PhD, discusses the role of concurrent molecular testing in lung cancer.
Advertisement
Latest Updated Articles
Dr. Boyle on Approaching Biomarker Testing in Lung CancerMarch 24th 2021
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
3
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis
4
CLL14 Final Analysis Shows Long-Term PFS Gain With Venetoclax/Obinutuzumab in Previously Untreated CLL
5